Back to UBS Group AG UBS Group AG

OCULOCUL
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in OCULAR THERAPEUTIX INC

UBS Group AG holds 1.6M shares of OCUL (OCULAR THERAPEUTIX INC), worth $15.2M as of 2026-Q2. The position was increased (+2.0% shares). OCUL represents 0.0% of UBS Group AG's portfolio.

Current Value

$15.2M

Current Shares

1.6M

Total Value Change

+$9.3M

Total Shares Change

+866,225

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+2.0%
$15.2M0.0%$9.82
29
2026-Q1
Increased
1.5M
+22.1%
$12.9M0.0%$10.76
34
2025-Q4
Decreased
1.2M
-0.3%
$15.1M0.0%$12.20
0
2025-Q3
Decreased
1.2M
-36.5%
$14.6M0.0%$12.53
0
2025-Q2
Increased
2M
+47.2%
$18.2M0.0%$9.22
39
2025-Q1
Increased
1.3M
+52.3%
$9.8M0.0%$7.58
39
2024-Q4
Increased
876,546
+28.0%
$7.5M0.0%$8.35
34
2024-Q3
Decreased
684,776
-8.5%
$6M0.0%$8.68
0

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used